In the history of pharmaceutical advertising, very few campaigns have changed a company’s public image as much as Pfizer’s “Science Will Win” campaign. Launched in 2020 during the COVID-19 pandemic, it was more than a television commercial. It became a global message of hope, trust, and scientific progress at a time when the world needed it most.
Interestingly, the campaign was not originally created because of COVID-19. Pfizer had already been working on a new corporate brand identity before the pandemic began. The company wanted to reposition itself from being known mainly for famous products such as Viagra to becoming recognized as a science-driven biopharmaceutical company focused on breakthrough innovation. When COVID-19 spread across the world, the campaign’s message became even more meaningful.
The Team Behind the Campaign
The campaign was developed by Grey New York, in collaboration with H+K Strategies and Landor & Fitch. Instead of promoting a specific medicine, the creative team focused on telling the story of the scientists, researchers, doctors, and healthcare professionals working behind the scenes to improve lives.
The television advertisements featured real laboratory environments, scientific research, and Pfizer employees. Rather than relying on dramatic marketing, the campaign ended with a simple but powerful message:
“Science Will Win.”
Leadership That Strengthened the Message
The campaign was strongly supported by Pfizer’s Chairman and Chief Executive Officer, Dr. Albert Bourla, who consistently emphasized that science should guide the company’s future. Under his leadership, Pfizer introduced its corporate purpose, “Breakthroughs That Change Patients’ Lives,” making the campaign a reflection of the company’s long-term vision rather than a short-term marketing effort.
This clear leadership message helped build credibility with patients, healthcare professionals, investors, and the general public.
Measurable Results and Industry Recognition
The campaign produced impressive results. According to Grey, it increased Pfizer’s brand awareness by 66% and improved brand favorability by 55% among audiences exposed to the campaign. It also reduced the ratio of anti-science conversations on social media by 33%, showing that its influence extended beyond traditional advertising.
Research by YouGov ranked “Science Will Win” among the Top 5 Most Effective U.S. Advertising Campaigns, highlighting its strong impact on public perception and brand trust.
Pfizer’s Business Performance During the Campaign
Although no official source attributes Pfizer’s financial growth directly to this advertising campaign, it supported one of the most important periods in the company’s history.
In 2020, Pfizer completed a major corporate transformation, launched its new brand identity, and partnered with BioNTech to develop one of the world’s first authorized COVID-19 vaccines.
Some key company figures from 2020 include:
- $41.9 billion in total revenue
- $9.4 billion invested in research and development
- Operations across 125+ countries
- Approximately 78,500 employees worldwide
These numbers demonstrate the scale of Pfizer’s operations during the period when the campaign was launched.
Why the Campaign Connected With People
One of the biggest reasons for the campaign’s success was its authenticity. Instead of featuring celebrities or making product-focused promises, Pfizer highlighted the real people behind medical discoveries.
The advertisements showcased laboratories, research, innovation, and teamwork. This helped audiences understand that creating medicines and vaccines requires years of dedication, testing, and collaboration.
During a time filled with uncertainty, the campaign offered something many people were searching for—confidence in science and hope for the future.
Awards and Lasting Impact
“Science Will Win” received recognition throughout the marketing industry. The campaign earned Effie recognition for marketing effectiveness and was praised by WPP and Grey as one of Pfizer’s most significant corporate branding initiatives.
More importantly, it reshaped how people viewed Pfizer. The campaign became the company’s global communication platform and continues to influence its branding strategy today.
Lessons for Business Leaders and Marketers
The success of “Science Will Win” offers valuable lessons for organizations in every industry.
First, build trust before trying to sell products. People are more likely to support brands they believe in.
Second, communicate your company’s purpose clearly. A meaningful mission creates stronger emotional connections than traditional advertising alone.
Third, maintain consistency across every communication channel. Pfizer delivered the same message through television, digital media, social platforms, and corporate communications, making the campaign more memorable.
Finally, invest in your brand before a crisis happens. Because Pfizer had already started transforming its identity before the pandemic, it was able to communicate with confidence when the world needed reassurance the most.
Conclusion
Pfizer’s “Science Will Win” campaign proved that great advertising is not always about promoting a product. Sometimes, it is about sharing a purpose that people can believe in.
By celebrating scientists, innovation, and the power of research, Pfizer created a campaign that strengthened public trust, improved its global reputation, and became one of the most successful corporate advertising campaigns in the company’s history. It remains a powerful example of how purpose-driven storytelling can create lasting value for both a brand and society.
Access our exclusive, data-rich dashboard dedicated to the healthcare market – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
About Us
Healthcare WebWire is a part of Towards Healthcare Research and Consulting is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.
You can place an order or ask any questions, please feel free to contact us at [email protected]
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium